Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1038/d41586-024-02515-1 | DOI Listing |
J Food Prot
January 2025
U.S. Food and Drug Administration, Office of the Commissioner, 10903 New Hampshire Ave., Silver Spring, MD 20993, USA.
Overly broad recalls following an FDA advisory occur when the source of an outbreak is originally misidentified or cannot be promptly identified. In this situation, an entire product category might be recalled (e.g.
View Article and Find Full Text PDFInt Arch Occup Environ Health
December 2024
Social Science and Occupational Health Research Group, National Institute of Occupational Safety and Health, Nagao 6-21-1, Tama-Ku, Kawasaki, 214-8585, Japan.
Purpose: We estimated the static and dynamic effects of promotion to managerial positions on mental health and satisfaction using the recent estimation method; we addressed the gap in extant research by considering the heterogeneity in treatment timing to reconfirm evidence regarding the causal effects of promotion.
Methods: We used a modified estimation method of two-way fixed effects recommended by (Callaway and Sant'Anna, J Econom 225:200-230, 2021). To check for robustness, we compared the analyses using propensity sample matching, an alternative treatment timing heterogeneity-robust analysis, and a normal two-way fixed effects event study.
JB JS Open Access
December 2024
Department of Orthopedic Surgery and Sports Medicine, University of Florida, Gainesville, Florida.
Introduction: Private equity (PE) investment in health care has increased more than 250% between 2010 and 2020. This is mirrored by an increasing number of published materials in medical journals. The objective of our study was to identify and characterize trends and key themes seen within publications discussing the topic of PE investment into orthopaedic surgery practices and bias within those publications.
View Article and Find Full Text PDFBackground: Few treatments are available for individuals with marked treatment-resistant depression (TRD).
Objective: Evaluate the safety and effectiveness of FDA-approved adjunctive vagus nerve stimulation (VNS) in patients with marked TRD.
Methods: This 12-month, multicenter, double-blind, sham-controlled trial included 493 adults with marked treatment-resistant major depression who were randomized to active or no-stimulation sham VNS for 12 months.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!